Pharmaceutical Discount Contracts Open-House Procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
30 / 100
Risk factors
No estimated contract value provided; cannot assess financial attractiveness.
Seven lots end on 31.12.2025 (1 year early). Additionally, any lot may be terminated early if IKK classic enters exclus...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Dec 2026
- Supply of pharmaceutical products for defined active substances
- Non-exclusive discount agreements under §130a Abs.8 SGB V
Show full summary
IKK classic is conducting an Open-House procedure for non-exclusive drug discount agreements under §130a Abs.8 SGB V for 41 active substances. The procedure runs from 01.01.2025 to 31.12.2026, with continuous entry possible until 05.11.2026. This notice is a modification: seven lots (Amoxicillin, Amoxicillin and clavulanic acid, Azithromycin, Cefuroxim, Ciprofloxacin, Clindamycin, Fosfomycin) will close early on 31.12.2025; the lot for Tacrolimus was adjusted. No estimated values are provided. Submission is via email or post (not electronic). Documents are available but were not analyzed. There is an inconsistency in EU funding flag (structured data says EU-funded, XML says no EU funds).
Risks
No estimated contract value provided; cannot assess financial attractiveness.
Seven lots end on 31.12.2025 (1 year early). Additionally, any lot may be terminated early if IKK classic enters exclus...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (or consortium) as defined in §4 Abs.18 AMG
Administrative
- Submit signed contract and all required documents (self-declarations, commercial register excerpt not older than 6 months)
- Submission via email or postal mail (electronic submission not allowed)
Requirements may be incomplete.
Buyer
Lots (41)
LOT-0001
Acalabrutinib (ATC L01EL02)
Supply of Acalabrutinib for non-exclusive discount agreement.
Location
Duration
Category
Award details
Acalabrutinib
ATC-Code: L01EL02
Show original TED data
Original lot title
Acalabrutinib; ATC-Code: L01EL02
Original TED description
Acalabrutinib; ATC-Code: L01EL02
LOT-0002
Amoxicillin (ATC J01CA04) - early end 31.12.2025
Supply of Amoxicillin for non-exclusive discount agreement. This lot closes early on 31.12.2025.
Location
Duration
Category
Award details
Amoxicillin
ATC-Code: J01CA04
Show original TED data
Original lot title
Amoxicillin; ATC-Code: J01CA04
Original TED description
Amoxicillin; ATC-Code: J01CA04
LOT-0003
Amoxicillin and clavulanic acid (ATC J01CR02) - early end 31.12.2025
Supply of Amoxicillin and clavulanic acid for non-exclusive discount agreement. This lot closes early on 31.12.2025.
Location
Duration
Category
Award details
Amoxicillin und Clavulansäure
ATC-Code: J01CR02
Show original TED data
Original lot title
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
Original TED description
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
LOT-0004
Azithromycin; ATC-Code: J01FA10
Azithromycin; ATC-Code: J01FA10
Location
Duration
Category
Award details
Azithromycin
ATC-Code: J01FA10
LOT-0005
Brigatinib; ATC-Code: L01ED04
Brigatinib; ATC-Code: L01ED04
Location
Duration
Category
Award details
Brigatinib
ATC-Code: L01ED04
LOT-0006
Capsaicin; ATC-Code: N01BX04
Capsaicin; ATC-Code: N01BX04
Location
Duration
Category
Award details
Capsaicin
ATC-Code: N01BX04
LOT-0007
Cefaclor; ATC-Code: J01DC04
Cefaclor; ATC-Code: J01DC04
Location
Duration
Category
Award details
Cefaclor
ATC-Code: J01DC04
LOT-0008
Cefpodoxim; ATC-Code: J01DD13
Cefpodoxim; ATC-Code: J01DD13
Location
Duration
Category
Award details
Cefpodoxim
ATC-Code: J01DD13
LOT-0009
Cefuroxim; ATC-Code: J01DC02
Cefuroxim; ATC-Code: J01DC02
Location
Duration
Category
Award details
Cefuroxim
ATC-Code: J01DC02
LOT-0010
Ciclopirox; Creme, Lösung; ATC-Code: D01AE14
Ciclopirox; Creme, Lösung; ATC-Code: D01AE14
Location
Duration
Category
Award details
Ciclopirox
Creme, Lösung
ATC-Code: D01AE14
LOT-0011
Ciprofloxacin; Filmtabletten, Trockensaft und Infusionslösung; ATC-Code: J01MA02
Ciprofloxacin; Filmtabletten, Trockensaft und Infusionslösung; ATC-Code: J01MA02
Location
Duration
Category
Award details
Ciprofloxacin
Filmtabletten, Trockensaft und Infusionslösung
ATC-Code: J01MA02
LOT-0012
Clarithromycin; ATC-Code: J01FA09
Clarithromycin; ATC-Code: J01FA09
Location
Duration
Category
Award details
Clarithromycin
ATC-Code: J01FA09
LOT-0013
Clindamycin; ATC-Code: J01FF01
Clindamycin; ATC-Code: J01FF01
Location
Duration
Category
Award details
Clindamycin
ATC-Code: J01FF01
LOT-0014
Dasatinib; 100 mg; Normgröße N2 und N3; ATC-Code: L01EA02
Dasatinib; 100 mg; Normgröße N2 und N3; ATC-Code: L01EA02
Location
Duration
Category
Award details
Dasatinib
100 mg
Normgröße N2 und N3
ATC-Code: L01EA02
LOT-0015
Dexamethason; Augentropfen; ATC-Code: S01BA01
Dexamethason; Augentropfen; ATC-Code: S01BA01
Location
Duration
Category
Award details
Dexamethason
Augentropfen
ATC-Code: S01BA01
LOT-0016
Diclofenac; Gel; Normgröße N1; ATC-Code: D11AX18
Diclofenac; Gel; Normgröße N1; ATC-Code: D11AX18
Location
Duration
Category
Award details
Diclofenac
Gel
Normgröße N1
ATC-Code: D11AX18
LOT-0017
Estradiol valerat; ATC-Code: G03CA03
Estradiol valerat; ATC-Code: G03CA03
Location
Duration
Category
Award details
Estradiol valerat
ATC-Code: G03CA03
LOT-0018
Etanercept; ATC-Code: L04AB01
Etanercept; ATC-Code: L04AB01
Location
Duration
Category
Award details
Etanercept
ATC-Code: L04AB01
LOT-0019
Fosfomycin; ATC-Code: J01XX01
Fosfomycin; ATC-Code: J01XX01
Location
Duration
Category
Award details
Fosfomycin
ATC-Code: J01XX01
LOT-0020
Ibuprofen; Retardtabletten; ATC-Code: M01AE01
Ibuprofen; Retardtabletten; ATC-Code: M01AE01
Location
Duration
Category
Award details
Ibuprofen
Retardtabletten
ATC-Code: M01AE01
LOT-0021
Ixazomib; ATC-Code: L01XG03
Ixazomib; ATC-Code: L01XG03
Location
Duration
Category
Award details
Ixazomib
ATC-Code: L01XG03
LOT-0022
Lanreotid; ATC-Code: H01CB03
Lanreotid; ATC-Code: H01CB03
Location
Duration
Category
Award details
Lanreotid
ATC-Code: H01CB03
LOT-0023
Lenograstim; ATC-Code: L03AA10
Lenograstim; ATC-Code: L03AA10
Location
Duration
Category
Award details
Lenograstim
ATC-Code: L03AA10
LOT-0024
Levofloxacin; ATC-Code: J01MA12
Levofloxacin; ATC-Code: J01MA12
Location
Duration
Category
Award details
Levofloxacin
ATC-Code: J01MA12
LOT-0025
Levonorgestrel 0,125 mg und Ethinylestradiol 0,03 mg; Überzogene Tabletten; ATC-Code: G03AA07
Levonorgestrel 0,125 mg und Ethinylestradiol 0,03 mg; Überzogene Tabletten; ATC-Code: G03AA07
Location
Duration
Category
Award details
Levonorgestrel 0,125 mg und Ethinylestradiol 0,03 mg
Überzogene Tabletten
ATC-Code: G03AA07
LOT-0026
Linezolid; ATC-Code: J01XX08
Linezolid; ATC-Code: J01XX08
Location
Duration
Category
Award details
Linezolid
ATC-Code: J01XX08
LOT-0027
Lipegfilgrastim; ATC-Code: L03AA14
Lipegfilgrastim; ATC-Code: L03AA14
Location
Duration
Category
Award details
Lipegfilgrastim
ATC-Code: L03AA14
LOT-0028
Liraglutid; ATC-Code: A10BJ02
Liraglutid; ATC-Code: A10BJ02
Location
Duration
Category
Award details
Liraglutid
ATC-Code: A10BJ02
LOT-0029
Megestrol; ATC-Code: L02AB01
Megestrol; ATC-Code: L02AB01
Location
Duration
Category
Award details
Megestrol
ATC-Code: L02AB01
LOT-0030
Metoprolol tartrat; Retardtabletten; Freisetzungskinetik 0. Ordnung (ZOK-Galenik); ATC-Code: C07AB02
Metoprolol tartrat; Retardtabletten; Freisetzungskinetik 0. Ordnung (ZOK-Galenik); ATC-Code: C07AB02
Location
Duration
Category
Award details
Metoprolol tartrat
Retardtabletten
Freisetzungskinetik 0. Ordnung (ZOK-Galenik)
ATC-Code: C07AB02
LOT-0031
Ofloxacin; ATC-Code: S01AE01
Ofloxacin; ATC-Code: S01AE01
Location
Duration
Category
Award details
Ofloxacin
ATC-Code: S01AE01
LOT-0032
Paliperidon; 25 mg pro Spritze und 50 mg pro Spritze; Depot-Injektionssuspension; ATC-Code: N05AX13
Paliperidon; 25 mg pro Spritze und 50 mg pro Spritze; Depot-Injektionssuspension; ATC-Code: N05AX13
Location
Duration
Category
Award details
Paliperidon
25 mg pro Spritze und 50 mg pro Spritze
Depot-Injektionssuspension
ATC-Code: N05AX13
LOT-0033
Phenoxymethylpenicillin; ATC-Code: J01CE02
Phenoxymethylpenicillin; ATC-Code: J01CE02
Location
Duration
Category
Award details
Phenoxymethylpenicillin
ATC-Code: J01CE02
LOT-0034
Ramipril, Amlodipin und Hydrochlorothiazid; ATC-Code: C09BX03
Ramipril, Amlodipin und Hydrochlorothiazid; ATC-Code: C09BX03
Location
Duration
Category
Award details
Ramipril, Amlodipin und Hydrochlorothiazid
ATC-Code: C09BX03
LOT-0035
Sevelamerhydrochlorid; ATC-Code: V03AE02
Sevelamerhydrochlorid; ATC-Code: V03AE02
Location
Duration
Category
Award details
Sevelamerhydrochlorid
ATC-Code: V03AE02
LOT-0036
Somatropin; ATC-Code: H01AC01
Somatropin; ATC-Code: H01AC01
Location
Duration
Category
Award details
Somatropin
ATC-Code: H01AC01
LOT-0037
Sultamicillin; ATC-Code: J01CR04
Sultamicillin; ATC-Code: J01CR04
Location
Duration
Category
Award details
Sultamicillin
ATC-Code: J01CR04
LOT-0038
Tacrolimus; Retardkapseln; ATC-Code: L04AD02
Tacrolimus; Retardkapseln; ATC-Code: L04AD02
Location
Duration
Category
Award details
Tacrolimus
Retardkapseln
ATC-Code: L04AD02
LOT-0039
Tacrolimus; Retardtabletten; ATC-Code: L04AD02
Tacrolimus; Retardtabletten; ATC-Code: L04AD02
Location
Duration
Category
Award details
Tacrolimus
Retardtabletten
ATC-Code: L04AD02
LOT-0040
Vancomycin; ATC-Code: A07AA09
Vancomycin; ATC-Code: A07AA09
Location
Duration
Category
Award details
Vancomycin
ATC-Code: A07AA09
LOT-0041
Ciclosporin; ATC-Code: L04AD01
Ciclosporin; ATC-Code: L04AD01
Location
Duration
Category
Award details
Ciclosporin
ATC-Code: L04AD01
Procurement Details
- Publication date
- 23 Nov 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 776037-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
30 / 100
Risk factors
No estimated contract value provided; cannot assess financial attractiveness.
Seven lots end on 31.12.2025 (1 year early). Additionally, any lot may be terminated early if IKK classic enters exclus...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications